Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00614783 · ClinicalTrials.gov registry record
Screening for Early Evidence of Diabetes
A clinical trial, sponsored by VeraLight.
- Completed
- Registry status
- 3,478
- Enrollment target
NCT00614783 is a clinical trial that has completed, run by VeraLight. The registered enrollment target is 3,478 participants.
The verdict
NCT00614783 has completed, sponsored by VeraLight.
- COMPLETED
- Registry status
- 3,478 participants
- Enrollment target
Study Summary
This is a pivotal study to determine the accuracy of a new device (SCOUT) in screening persons for pre-diabetes or diabetes. SCOUT will be compared to the standard screening test (Fasting Plasma Glucose), using the Oral Glucose Tolerance Test as the reference standard. SCOUT uses a rapid, noninvasive, light-based technology to measure the concentration of chemicals in the skin called advanced glycation endproducts (AGEs). Several studies have demonstrated that AGEs accumulate in skin faster in individuals with poor control of blood sugar. Persons will be eligible for the study if they are 'at risk' for diabetes based on their age and other risk factors as defined by the American Diabetes Association.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,478 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00614783
The ClinicalTrials.gov registry entry for NCT00614783 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,478 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VeraLight, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00614783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00614783 about?
NCT00614783 is a clinical study titled "Screening for Early Evidence of Diabetes". This is a pivotal study to determine the accuracy of a new device (SCOUT) in screening persons for pre-diabetes or diabetes. SCOUT will be compared to the standard screening test (Fasting Plasma Glucose), using the Oral Glucose Tolerance Test as the reference standard. SCOUT uses a rapid, noninvasi...
What is the current status of trial NCT00614783?
This trial is currently completed. The enrollment target is 3,478 participants. The study started on 2007-05. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT00614783?
This trial is sponsored by VeraLight, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.